Grigorios Siokas Purchases 174,172 Shares of Cosmos Health Inc. (NASDAQ:COSM) Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas bought 174,172 shares of the stock in a transaction that occurred on Wednesday, May 21st. The stock was purchased at an average price of $0.47 per share, for a total transaction of $81,860.84. Following the completion of the purchase, the chief executive officer now directly owns 5,983,055 shares in the company, valued at $2,812,035.85. The trade was a 3.00% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Grigorios Siokas also recently made the following trade(s):

• On Thursday, May 22nd, Grigorios Siokas bought 141,825 shares of Cosmos Health stock. The stock was purchased at an average price of $0.44 per share, for a total transaction of $62,403.00.
• On Tuesday, May 20th, Grigorios Siokas bought 147,563 shares of Cosmos Health stock. The stock was purchased at an average price of $0.45 per share, for a total transaction of $66,403.35.
• On Monday, May 19th, Grigorios Siokas bought 79,254 shares of Cosmos Health stock. The stock was purchased at an average price of $0.43 per share, for a total transaction of $34,079.22.
• On Wednesday, April 23rd, Grigorios Siokas bought 205,000 shares of Cosmos Health stock. The stock was purchased at an average price of $0.40 per share, for a total transaction of $82,000.00.
• On Monday, April 21st, Grigorios Siokas bought 654,912 shares of Cosmos Health stock. The stock was purchased at an average price of $0.32 per share, for a total transaction of $209,571.84.
• On Monday, March 3rd, Grigorios Siokas purchased 132,572 shares of Cosmos Health stock. The stock was bought at an average price of $0.49 per share, for a total transaction of $64,960.28.
• On Monday, February 24th, Grigorios Siokas purchased 354,296 shares of Cosmos Health stock. The stock was bought at an average price of $0.56 per share, for a total transaction of $198,405.76.

Cosmos Health Stock Performance

NASDAQ COSM opened at $0.45 on Friday. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.44 and a quick ratio of 1.24. The firm has a market capitalization of $12.87 million, a price-to-earnings ratio of -0.18 and a beta of 5.50. The company’s fifty day moving average is $0.42 and its two-hundred day moving average is $0.59. Cosmos Health Inc. has a 52-week low of $0.28 and a 52-week high of $1.58.

Cosmos Health (NASDAQ:COSM) last posted its quarterly earnings results on Thursday, May 15th. The company reported $0.01 earnings per share (EPS) for the quarter. Cosmos Health had a negative net margin of 36.39% and a negative return on equity of 9.39%. Equities research analysts forecast that Cosmos Health Inc. will post -0.78 EPS for the current year.

Institutional Trading of Cosmos Health

An institutional investor recently raised its position in Cosmos Health stock. Geode Capital Management LLC grew its stake in Cosmos Health Inc. (NASDAQ:COSM) by 29.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 193,432 shares of the company’s stock after purchasing an additional 43,704 shares during the period. Geode Capital Management LLC owned about 0.83% of Cosmos Health worth $129,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 12.61% of the company’s stock.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.